Global Drug Eluting Beads Market Growth 2025-2031
The global Drug Eluting Beads market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Drug Eluting Beads Industry Forecast” looks at past sales and reviews total world Drug Eluting Beads sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Eluting Beads sales for 2025 through 2031. With Drug Eluting Beads sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Beads industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Beads landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Beads portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Eluting Beads market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Beads and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Beads.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Beads market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Drug Eluting Beads market?
What factors are driving Drug Eluting Beads market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Beads market opportunities vary by end market size?
How does Drug Eluting Beads break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Drug Eluting Beads Industry Forecast” looks at past sales and reviews total world Drug Eluting Beads sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Eluting Beads sales for 2025 through 2031. With Drug Eluting Beads sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Beads industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Beads landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Beads portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Eluting Beads market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Beads and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Beads.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Beads market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oncozene Beads
- Quadra Sphere
- LC Beads
- Others
- Hospitals
- Specialized Clinics
- Research Centers
- Ambulatory Surgical Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biocompatibles
- BTG International
- Merit Medical Systems
- CeloNova BioSciences
- ABK Biomedical
- Boston Scientific
- Medtronic
- Merit Medical Systems
- Surefire Medical
- Terumo
What is the 10-year outlook for the global Drug Eluting Beads market?
What factors are driving Drug Eluting Beads market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Beads market opportunities vary by end market size?
How does Drug Eluting Beads break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Beads Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Drug Eluting Beads by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Drug Eluting Beads by Country/Region, 2020, 2024 & 2031
2.2 Drug Eluting Beads Segment by Type
2.2.1 Oncozene Beads
2.2.2 Quadra Sphere
2.2.3 LC Beads
2.2.4 Others
2.3 Drug Eluting Beads Sales by Type
2.3.1 Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
2.3.2 Global Drug Eluting Beads Revenue and Market Share by Type (2020-2025)
2.3.3 Global Drug Eluting Beads Sale Price by Type (2020-2025)
2.4 Drug Eluting Beads Segment by Application
2.4.1 Hospitals
2.4.2 Specialized Clinics
2.4.3 Research Centers
2.4.4 Ambulatory Surgical Centers
2.5 Drug Eluting Beads Sales by Application
2.5.1 Global Drug Eluting Beads Sale Market Share by Application (2020-2025)
2.5.2 Global Drug Eluting Beads Revenue and Market Share by Application (2020-2025)
2.5.3 Global Drug Eluting Beads Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Beads Breakdown Data by Company
3.1.1 Global Drug Eluting Beads Annual Sales by Company (2020-2025)
3.1.2 Global Drug Eluting Beads Sales Market Share by Company (2020-2025)
3.2 Global Drug Eluting Beads Annual Revenue by Company (2020-2025)
3.2.1 Global Drug Eluting Beads Revenue by Company (2020-2025)
3.2.2 Global Drug Eluting Beads Revenue Market Share by Company (2020-2025)
3.3 Global Drug Eluting Beads Sale Price by Company
3.4 Key Manufacturers Drug Eluting Beads Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Beads Product Location Distribution
3.4.2 Players Drug Eluting Beads Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BEADS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Beads Market Size by Geographic Region (2020-2025)
4.1.1 Global Drug Eluting Beads Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Drug Eluting Beads Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Drug Eluting Beads Market Size by Country/Region (2020-2025)
4.2.1 Global Drug Eluting Beads Annual Sales by Country/Region (2020-2025)
4.2.2 Global Drug Eluting Beads Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Eluting Beads Sales Growth
4.4 APAC Drug Eluting Beads Sales Growth
4.5 Europe Drug Eluting Beads Sales Growth
4.6 Middle East & Africa Drug Eluting Beads Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Beads Sales by Country
5.1.1 Americas Drug Eluting Beads Sales by Country (2020-2025)
5.1.2 Americas Drug Eluting Beads Revenue by Country (2020-2025)
5.2 Americas Drug Eluting Beads Sales by Type (2020-2025)
5.3 Americas Drug Eluting Beads Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Beads Sales by Region
6.1.1 APAC Drug Eluting Beads Sales by Region (2020-2025)
6.1.2 APAC Drug Eluting Beads Revenue by Region (2020-2025)
6.2 APAC Drug Eluting Beads Sales by Type (2020-2025)
6.3 APAC Drug Eluting Beads Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Beads by Country
7.1.1 Europe Drug Eluting Beads Sales by Country (2020-2025)
7.1.2 Europe Drug Eluting Beads Revenue by Country (2020-2025)
7.2 Europe Drug Eluting Beads Sales by Type (2020-2025)
7.3 Europe Drug Eluting Beads Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Beads by Country
8.1.1 Middle East & Africa Drug Eluting Beads Sales by Country (2020-2025)
8.1.2 Middle East & Africa Drug Eluting Beads Revenue by Country (2020-2025)
8.2 Middle East & Africa Drug Eluting Beads Sales by Type (2020-2025)
8.3 Middle East & Africa Drug Eluting Beads Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Beads
10.3 Manufacturing Process Analysis of Drug Eluting Beads
10.4 Industry Chain Structure of Drug Eluting Beads
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Beads Distributors
11.3 Drug Eluting Beads Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BEADS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Beads Market Size Forecast by Region
12.1.1 Global Drug Eluting Beads Forecast by Region (2026-2031)
12.1.2 Global Drug Eluting Beads Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Drug Eluting Beads Forecast by Type (2026-2031)
12.7 Global Drug Eluting Beads Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Biocompatibles
13.1.1 Biocompatibles Company Information
13.1.2 Biocompatibles Drug Eluting Beads Product Portfolios and Specifications
13.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Biocompatibles Main Business Overview
13.1.5 Biocompatibles Latest Developments
13.2 BTG International
13.2.1 BTG International Company Information
13.2.2 BTG International Drug Eluting Beads Product Portfolios and Specifications
13.2.3 BTG International Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BTG International Main Business Overview
13.2.5 BTG International Latest Developments
13.3 Merit Medical Systems
13.3.1 Merit Medical Systems Company Information
13.3.2 Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
13.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merit Medical Systems Main Business Overview
13.3.5 Merit Medical Systems Latest Developments
13.4 CeloNova BioSciences
13.4.1 CeloNova BioSciences Company Information
13.4.2 CeloNova BioSciences Drug Eluting Beads Product Portfolios and Specifications
13.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CeloNova BioSciences Main Business Overview
13.4.5 CeloNova BioSciences Latest Developments
13.5 ABK Biomedical
13.5.1 ABK Biomedical Company Information
13.5.2 ABK Biomedical Drug Eluting Beads Product Portfolios and Specifications
13.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ABK Biomedical Main Business Overview
13.5.5 ABK Biomedical Latest Developments
13.6 Boston Scientific
13.6.1 Boston Scientific Company Information
13.6.2 Boston Scientific Drug Eluting Beads Product Portfolios and Specifications
13.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boston Scientific Main Business Overview
13.6.5 Boston Scientific Latest Developments
13.7 Medtronic
13.7.1 Medtronic Company Information
13.7.2 Medtronic Drug Eluting Beads Product Portfolios and Specifications
13.7.3 Medtronic Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Medtronic Main Business Overview
13.7.5 Medtronic Latest Developments
13.8 Merit Medical Systems
13.8.1 Merit Medical Systems Company Information
13.8.2 Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
13.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merit Medical Systems Main Business Overview
13.8.5 Merit Medical Systems Latest Developments
13.9 Surefire Medical
13.9.1 Surefire Medical Company Information
13.9.2 Surefire Medical Drug Eluting Beads Product Portfolios and Specifications
13.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Surefire Medical Main Business Overview
13.9.5 Surefire Medical Latest Developments
13.10 Terumo
13.10.1 Terumo Company Information
13.10.2 Terumo Drug Eluting Beads Product Portfolios and Specifications
13.10.3 Terumo Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Terumo Main Business Overview
13.10.5 Terumo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Beads Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Drug Eluting Beads by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Drug Eluting Beads by Country/Region, 2020, 2024 & 2031
2.2 Drug Eluting Beads Segment by Type
2.2.1 Oncozene Beads
2.2.2 Quadra Sphere
2.2.3 LC Beads
2.2.4 Others
2.3 Drug Eluting Beads Sales by Type
2.3.1 Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
2.3.2 Global Drug Eluting Beads Revenue and Market Share by Type (2020-2025)
2.3.3 Global Drug Eluting Beads Sale Price by Type (2020-2025)
2.4 Drug Eluting Beads Segment by Application
2.4.1 Hospitals
2.4.2 Specialized Clinics
2.4.3 Research Centers
2.4.4 Ambulatory Surgical Centers
2.5 Drug Eluting Beads Sales by Application
2.5.1 Global Drug Eluting Beads Sale Market Share by Application (2020-2025)
2.5.2 Global Drug Eluting Beads Revenue and Market Share by Application (2020-2025)
2.5.3 Global Drug Eluting Beads Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Beads Breakdown Data by Company
3.1.1 Global Drug Eluting Beads Annual Sales by Company (2020-2025)
3.1.2 Global Drug Eluting Beads Sales Market Share by Company (2020-2025)
3.2 Global Drug Eluting Beads Annual Revenue by Company (2020-2025)
3.2.1 Global Drug Eluting Beads Revenue by Company (2020-2025)
3.2.2 Global Drug Eluting Beads Revenue Market Share by Company (2020-2025)
3.3 Global Drug Eluting Beads Sale Price by Company
3.4 Key Manufacturers Drug Eluting Beads Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Beads Product Location Distribution
3.4.2 Players Drug Eluting Beads Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BEADS BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Beads Market Size by Geographic Region (2020-2025)
4.1.1 Global Drug Eluting Beads Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Drug Eluting Beads Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Drug Eluting Beads Market Size by Country/Region (2020-2025)
4.2.1 Global Drug Eluting Beads Annual Sales by Country/Region (2020-2025)
4.2.2 Global Drug Eluting Beads Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Eluting Beads Sales Growth
4.4 APAC Drug Eluting Beads Sales Growth
4.5 Europe Drug Eluting Beads Sales Growth
4.6 Middle East & Africa Drug Eluting Beads Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Beads Sales by Country
5.1.1 Americas Drug Eluting Beads Sales by Country (2020-2025)
5.1.2 Americas Drug Eluting Beads Revenue by Country (2020-2025)
5.2 Americas Drug Eluting Beads Sales by Type (2020-2025)
5.3 Americas Drug Eluting Beads Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Beads Sales by Region
6.1.1 APAC Drug Eluting Beads Sales by Region (2020-2025)
6.1.2 APAC Drug Eluting Beads Revenue by Region (2020-2025)
6.2 APAC Drug Eluting Beads Sales by Type (2020-2025)
6.3 APAC Drug Eluting Beads Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Beads by Country
7.1.1 Europe Drug Eluting Beads Sales by Country (2020-2025)
7.1.2 Europe Drug Eluting Beads Revenue by Country (2020-2025)
7.2 Europe Drug Eluting Beads Sales by Type (2020-2025)
7.3 Europe Drug Eluting Beads Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Beads by Country
8.1.1 Middle East & Africa Drug Eluting Beads Sales by Country (2020-2025)
8.1.2 Middle East & Africa Drug Eluting Beads Revenue by Country (2020-2025)
8.2 Middle East & Africa Drug Eluting Beads Sales by Type (2020-2025)
8.3 Middle East & Africa Drug Eluting Beads Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Beads
10.3 Manufacturing Process Analysis of Drug Eluting Beads
10.4 Industry Chain Structure of Drug Eluting Beads
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Beads Distributors
11.3 Drug Eluting Beads Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BEADS BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Beads Market Size Forecast by Region
12.1.1 Global Drug Eluting Beads Forecast by Region (2026-2031)
12.1.2 Global Drug Eluting Beads Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Drug Eluting Beads Forecast by Type (2026-2031)
12.7 Global Drug Eluting Beads Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Biocompatibles
13.1.1 Biocompatibles Company Information
13.1.2 Biocompatibles Drug Eluting Beads Product Portfolios and Specifications
13.1.3 Biocompatibles Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Biocompatibles Main Business Overview
13.1.5 Biocompatibles Latest Developments
13.2 BTG International
13.2.1 BTG International Company Information
13.2.2 BTG International Drug Eluting Beads Product Portfolios and Specifications
13.2.3 BTG International Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BTG International Main Business Overview
13.2.5 BTG International Latest Developments
13.3 Merit Medical Systems
13.3.1 Merit Medical Systems Company Information
13.3.2 Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
13.3.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merit Medical Systems Main Business Overview
13.3.5 Merit Medical Systems Latest Developments
13.4 CeloNova BioSciences
13.4.1 CeloNova BioSciences Company Information
13.4.2 CeloNova BioSciences Drug Eluting Beads Product Portfolios and Specifications
13.4.3 CeloNova BioSciences Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CeloNova BioSciences Main Business Overview
13.4.5 CeloNova BioSciences Latest Developments
13.5 ABK Biomedical
13.5.1 ABK Biomedical Company Information
13.5.2 ABK Biomedical Drug Eluting Beads Product Portfolios and Specifications
13.5.3 ABK Biomedical Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ABK Biomedical Main Business Overview
13.5.5 ABK Biomedical Latest Developments
13.6 Boston Scientific
13.6.1 Boston Scientific Company Information
13.6.2 Boston Scientific Drug Eluting Beads Product Portfolios and Specifications
13.6.3 Boston Scientific Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boston Scientific Main Business Overview
13.6.5 Boston Scientific Latest Developments
13.7 Medtronic
13.7.1 Medtronic Company Information
13.7.2 Medtronic Drug Eluting Beads Product Portfolios and Specifications
13.7.3 Medtronic Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Medtronic Main Business Overview
13.7.5 Medtronic Latest Developments
13.8 Merit Medical Systems
13.8.1 Merit Medical Systems Company Information
13.8.2 Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
13.8.3 Merit Medical Systems Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merit Medical Systems Main Business Overview
13.8.5 Merit Medical Systems Latest Developments
13.9 Surefire Medical
13.9.1 Surefire Medical Company Information
13.9.2 Surefire Medical Drug Eluting Beads Product Portfolios and Specifications
13.9.3 Surefire Medical Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Surefire Medical Main Business Overview
13.9.5 Surefire Medical Latest Developments
13.10 Terumo
13.10.1 Terumo Company Information
13.10.2 Terumo Drug Eluting Beads Product Portfolios and Specifications
13.10.3 Terumo Drug Eluting Beads Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Terumo Main Business Overview
13.10.5 Terumo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Beads Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Drug Eluting Beads Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oncozene Beads
Table 4. Major Players of Quadra Sphere
Table 5. Major Players of LC Beads
Table 6. Major Players of Others
Table 7. Global Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 8. Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
Table 9. Global Drug Eluting Beads Revenue by Type (2020-2025) & ($ million)
Table 10. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
Table 11. Global Drug Eluting Beads Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Drug Eluting Beads Sale by Application (2020-2025) & (K Units)
Table 13. Global Drug Eluting Beads Sale Market Share by Application (2020-2025)
Table 14. Global Drug Eluting Beads Revenue by Application (2020-2025) & ($ million)
Table 15. Global Drug Eluting Beads Revenue Market Share by Application (2020-2025)
Table 16. Global Drug Eluting Beads Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Drug Eluting Beads Sales by Company (2020-2025) & (K Units)
Table 18. Global Drug Eluting Beads Sales Market Share by Company (2020-2025)
Table 19. Global Drug Eluting Beads Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Drug Eluting Beads Revenue Market Share by Company (2020-2025)
Table 21. Global Drug Eluting Beads Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Drug Eluting Beads Producing Area Distribution and Sales Area
Table 23. Players Drug Eluting Beads Products Offered
Table 24. Drug Eluting Beads Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Drug Eluting Beads Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Drug Eluting Beads Sales Market Share Geographic Region (2020-2025)
Table 29. Global Drug Eluting Beads Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Drug Eluting Beads Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Drug Eluting Beads Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Drug Eluting Beads Sales Market Share by Country/Region (2020-2025)
Table 33. Global Drug Eluting Beads Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Drug Eluting Beads Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 36. Americas Drug Eluting Beads Sales Market Share by Country (2020-2025)
Table 37. Americas Drug Eluting Beads Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 39. Americas Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 40. APAC Drug Eluting Beads Sales by Region (2020-2025) & (K Units)
Table 41. APAC Drug Eluting Beads Sales Market Share by Region (2020-2025)
Table 42. APAC Drug Eluting Beads Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 44. APAC Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 45. Europe Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 46. Europe Drug Eluting Beads Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 48. Europe Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Drug Eluting Beads
Table 54. Key Market Challenges & Risks of Drug Eluting Beads
Table 55. Key Industry Trends of Drug Eluting Beads
Table 56. Drug Eluting Beads Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Drug Eluting Beads Distributors List
Table 59. Drug Eluting Beads Customer List
Table 60. Global Drug Eluting Beads Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Drug Eluting Beads Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Drug Eluting Beads Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Drug Eluting Beads Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Drug Eluting Beads Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Drug Eluting Beads Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Drug Eluting Beads Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Drug Eluting Beads Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Drug Eluting Beads Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Drug Eluting Beads Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Drug Eluting Beads Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Biocompatibles Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 75. Biocompatibles Drug Eluting Beads Product Portfolios and Specifications
Table 76. Biocompatibles Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Biocompatibles Main Business
Table 78. Biocompatibles Latest Developments
Table 79. BTG International Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 80. BTG International Drug Eluting Beads Product Portfolios and Specifications
Table 81. BTG International Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. BTG International Main Business
Table 83. BTG International Latest Developments
Table 84. Merit Medical Systems Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 85. Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
Table 86. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merit Medical Systems Main Business
Table 88. Merit Medical Systems Latest Developments
Table 89. CeloNova BioSciences Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 90. CeloNova BioSciences Drug Eluting Beads Product Portfolios and Specifications
Table 91. CeloNova BioSciences Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. CeloNova BioSciences Main Business
Table 93. CeloNova BioSciences Latest Developments
Table 94. ABK Biomedical Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 95. ABK Biomedical Drug Eluting Beads Product Portfolios and Specifications
Table 96. ABK Biomedical Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. ABK Biomedical Main Business
Table 98. ABK Biomedical Latest Developments
Table 99. Boston Scientific Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Drug Eluting Beads Product Portfolios and Specifications
Table 101. Boston Scientific Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Boston Scientific Main Business
Table 103. Boston Scientific Latest Developments
Table 104. Medtronic Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic Drug Eluting Beads Product Portfolios and Specifications
Table 106. Medtronic Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Medtronic Main Business
Table 108. Medtronic Latest Developments
Table 109. Merit Medical Systems Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 110. Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
Table 111. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Merit Medical Systems Main Business
Table 113. Merit Medical Systems Latest Developments
Table 114. Surefire Medical Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 115. Surefire Medical Drug Eluting Beads Product Portfolios and Specifications
Table 116. Surefire Medical Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Surefire Medical Main Business
Table 118. Surefire Medical Latest Developments
Table 119. Terumo Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 120. Terumo Drug Eluting Beads Product Portfolios and Specifications
Table 121. Terumo Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Terumo Main Business
Table 123. Terumo Latest Developments
Table 1. Drug Eluting Beads Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Drug Eluting Beads Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oncozene Beads
Table 4. Major Players of Quadra Sphere
Table 5. Major Players of LC Beads
Table 6. Major Players of Others
Table 7. Global Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 8. Global Drug Eluting Beads Sales Market Share by Type (2020-2025)
Table 9. Global Drug Eluting Beads Revenue by Type (2020-2025) & ($ million)
Table 10. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
Table 11. Global Drug Eluting Beads Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Drug Eluting Beads Sale by Application (2020-2025) & (K Units)
Table 13. Global Drug Eluting Beads Sale Market Share by Application (2020-2025)
Table 14. Global Drug Eluting Beads Revenue by Application (2020-2025) & ($ million)
Table 15. Global Drug Eluting Beads Revenue Market Share by Application (2020-2025)
Table 16. Global Drug Eluting Beads Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Drug Eluting Beads Sales by Company (2020-2025) & (K Units)
Table 18. Global Drug Eluting Beads Sales Market Share by Company (2020-2025)
Table 19. Global Drug Eluting Beads Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Drug Eluting Beads Revenue Market Share by Company (2020-2025)
Table 21. Global Drug Eluting Beads Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Drug Eluting Beads Producing Area Distribution and Sales Area
Table 23. Players Drug Eluting Beads Products Offered
Table 24. Drug Eluting Beads Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Drug Eluting Beads Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Drug Eluting Beads Sales Market Share Geographic Region (2020-2025)
Table 29. Global Drug Eluting Beads Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Drug Eluting Beads Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Drug Eluting Beads Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Drug Eluting Beads Sales Market Share by Country/Region (2020-2025)
Table 33. Global Drug Eluting Beads Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Drug Eluting Beads Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 36. Americas Drug Eluting Beads Sales Market Share by Country (2020-2025)
Table 37. Americas Drug Eluting Beads Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 39. Americas Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 40. APAC Drug Eluting Beads Sales by Region (2020-2025) & (K Units)
Table 41. APAC Drug Eluting Beads Sales Market Share by Region (2020-2025)
Table 42. APAC Drug Eluting Beads Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 44. APAC Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 45. Europe Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 46. Europe Drug Eluting Beads Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 48. Europe Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Drug Eluting Beads Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Drug Eluting Beads Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Drug Eluting Beads Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Drug Eluting Beads
Table 54. Key Market Challenges & Risks of Drug Eluting Beads
Table 55. Key Industry Trends of Drug Eluting Beads
Table 56. Drug Eluting Beads Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Drug Eluting Beads Distributors List
Table 59. Drug Eluting Beads Customer List
Table 60. Global Drug Eluting Beads Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Drug Eluting Beads Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Drug Eluting Beads Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Drug Eluting Beads Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Drug Eluting Beads Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Drug Eluting Beads Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Drug Eluting Beads Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Drug Eluting Beads Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Drug Eluting Beads Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Drug Eluting Beads Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Drug Eluting Beads Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Drug Eluting Beads Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Biocompatibles Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 75. Biocompatibles Drug Eluting Beads Product Portfolios and Specifications
Table 76. Biocompatibles Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Biocompatibles Main Business
Table 78. Biocompatibles Latest Developments
Table 79. BTG International Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 80. BTG International Drug Eluting Beads Product Portfolios and Specifications
Table 81. BTG International Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. BTG International Main Business
Table 83. BTG International Latest Developments
Table 84. Merit Medical Systems Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 85. Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
Table 86. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merit Medical Systems Main Business
Table 88. Merit Medical Systems Latest Developments
Table 89. CeloNova BioSciences Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 90. CeloNova BioSciences Drug Eluting Beads Product Portfolios and Specifications
Table 91. CeloNova BioSciences Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. CeloNova BioSciences Main Business
Table 93. CeloNova BioSciences Latest Developments
Table 94. ABK Biomedical Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 95. ABK Biomedical Drug Eluting Beads Product Portfolios and Specifications
Table 96. ABK Biomedical Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. ABK Biomedical Main Business
Table 98. ABK Biomedical Latest Developments
Table 99. Boston Scientific Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Drug Eluting Beads Product Portfolios and Specifications
Table 101. Boston Scientific Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Boston Scientific Main Business
Table 103. Boston Scientific Latest Developments
Table 104. Medtronic Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic Drug Eluting Beads Product Portfolios and Specifications
Table 106. Medtronic Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Medtronic Main Business
Table 108. Medtronic Latest Developments
Table 109. Merit Medical Systems Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 110. Merit Medical Systems Drug Eluting Beads Product Portfolios and Specifications
Table 111. Merit Medical Systems Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Merit Medical Systems Main Business
Table 113. Merit Medical Systems Latest Developments
Table 114. Surefire Medical Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 115. Surefire Medical Drug Eluting Beads Product Portfolios and Specifications
Table 116. Surefire Medical Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Surefire Medical Main Business
Table 118. Surefire Medical Latest Developments
Table 119. Terumo Basic Information, Drug Eluting Beads Manufacturing Base, Sales Area and Its Competitors
Table 120. Terumo Drug Eluting Beads Product Portfolios and Specifications
Table 121. Terumo Drug Eluting Beads Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Terumo Main Business
Table 123. Terumo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Beads
Figure 2. Drug Eluting Beads Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Beads Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Drug Eluting Beads Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Drug Eluting Beads Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Drug Eluting Beads Sales Market Share by Country/Region (2024)
Figure 10. Drug Eluting Beads Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oncozene Beads
Figure 12. Product Picture of Quadra Sphere
Figure 13. Product Picture of LC Beads
Figure 14. Product Picture of Others
Figure 15. Global Drug Eluting Beads Sales Market Share by Type in 2025
Figure 16. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
Figure 17. Drug Eluting Beads Consumed in Hospitals
Figure 18. Global Drug Eluting Beads Market: Hospitals (2020-2025) & (K Units)
Figure 19. Drug Eluting Beads Consumed in Specialized Clinics
Figure 20. Global Drug Eluting Beads Market: Specialized Clinics (2020-2025) & (K Units)
Figure 21. Drug Eluting Beads Consumed in Research Centers
Figure 22. Global Drug Eluting Beads Market: Research Centers (2020-2025) & (K Units)
Figure 23. Drug Eluting Beads Consumed in Ambulatory Surgical Centers
Figure 24. Global Drug Eluting Beads Market: Ambulatory Surgical Centers (2020-2025) & (K Units)
Figure 25. Global Drug Eluting Beads Sale Market Share by Application (2024)
Figure 26. Global Drug Eluting Beads Revenue Market Share by Application in 2025
Figure 27. Drug Eluting Beads Sales by Company in 2025 (K Units)
Figure 28. Global Drug Eluting Beads Sales Market Share by Company in 2025
Figure 29. Drug Eluting Beads Revenue by Company in 2025 ($ millions)
Figure 30. Global Drug Eluting Beads Revenue Market Share by Company in 2025
Figure 31. Global Drug Eluting Beads Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Drug Eluting Beads Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 34. Americas Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 35. APAC Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 36. APAC Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 37. Europe Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 38. Europe Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 41. Americas Drug Eluting Beads Sales Market Share by Country in 2025
Figure 42. Americas Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Figure 43. Americas Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 44. Americas Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 45. United States Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Drug Eluting Beads Sales Market Share by Region in 2025
Figure 50. APAC Drug Eluting Beads Revenue Market Share by Region (2020-2025)
Figure 51. APAC Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 52. APAC Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 53. China Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 57. India Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Drug Eluting Beads Sales Market Share by Country in 2025
Figure 61. Europe Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Figure 62. Europe Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 63. Europe Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 64. Germany Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 65. France Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Drug Eluting Beads Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 72. Egypt Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Drug Eluting Beads in 2025
Figure 78. Manufacturing Process Analysis of Drug Eluting Beads
Figure 79. Industry Chain Structure of Drug Eluting Beads
Figure 80. Channels of Distribution
Figure 81. Global Drug Eluting Beads Sales Market Forecast by Region (2026-2031)
Figure 82. Global Drug Eluting Beads Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Drug Eluting Beads Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Drug Eluting Beads Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Drug Eluting Beads Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Drug Eluting Beads Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Drug Eluting Beads
Figure 2. Drug Eluting Beads Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Beads Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Drug Eluting Beads Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Drug Eluting Beads Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Drug Eluting Beads Sales Market Share by Country/Region (2024)
Figure 10. Drug Eluting Beads Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oncozene Beads
Figure 12. Product Picture of Quadra Sphere
Figure 13. Product Picture of LC Beads
Figure 14. Product Picture of Others
Figure 15. Global Drug Eluting Beads Sales Market Share by Type in 2025
Figure 16. Global Drug Eluting Beads Revenue Market Share by Type (2020-2025)
Figure 17. Drug Eluting Beads Consumed in Hospitals
Figure 18. Global Drug Eluting Beads Market: Hospitals (2020-2025) & (K Units)
Figure 19. Drug Eluting Beads Consumed in Specialized Clinics
Figure 20. Global Drug Eluting Beads Market: Specialized Clinics (2020-2025) & (K Units)
Figure 21. Drug Eluting Beads Consumed in Research Centers
Figure 22. Global Drug Eluting Beads Market: Research Centers (2020-2025) & (K Units)
Figure 23. Drug Eluting Beads Consumed in Ambulatory Surgical Centers
Figure 24. Global Drug Eluting Beads Market: Ambulatory Surgical Centers (2020-2025) & (K Units)
Figure 25. Global Drug Eluting Beads Sale Market Share by Application (2024)
Figure 26. Global Drug Eluting Beads Revenue Market Share by Application in 2025
Figure 27. Drug Eluting Beads Sales by Company in 2025 (K Units)
Figure 28. Global Drug Eluting Beads Sales Market Share by Company in 2025
Figure 29. Drug Eluting Beads Revenue by Company in 2025 ($ millions)
Figure 30. Global Drug Eluting Beads Revenue Market Share by Company in 2025
Figure 31. Global Drug Eluting Beads Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Drug Eluting Beads Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 34. Americas Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 35. APAC Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 36. APAC Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 37. Europe Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 38. Europe Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Drug Eluting Beads Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Drug Eluting Beads Revenue 2020-2025 ($ millions)
Figure 41. Americas Drug Eluting Beads Sales Market Share by Country in 2025
Figure 42. Americas Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Figure 43. Americas Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 44. Americas Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 45. United States Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Drug Eluting Beads Sales Market Share by Region in 2025
Figure 50. APAC Drug Eluting Beads Revenue Market Share by Region (2020-2025)
Figure 51. APAC Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 52. APAC Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 53. China Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 57. India Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Drug Eluting Beads Sales Market Share by Country in 2025
Figure 61. Europe Drug Eluting Beads Revenue Market Share by Country (2020-2025)
Figure 62. Europe Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 63. Europe Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 64. Germany Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 65. France Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Drug Eluting Beads Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Drug Eluting Beads Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Drug Eluting Beads Sales Market Share by Application (2020-2025)
Figure 72. Egypt Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Drug Eluting Beads Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Drug Eluting Beads in 2025
Figure 78. Manufacturing Process Analysis of Drug Eluting Beads
Figure 79. Industry Chain Structure of Drug Eluting Beads
Figure 80. Channels of Distribution
Figure 81. Global Drug Eluting Beads Sales Market Forecast by Region (2026-2031)
Figure 82. Global Drug Eluting Beads Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Drug Eluting Beads Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Drug Eluting Beads Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Drug Eluting Beads Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Drug Eluting Beads Revenue Market Share Forecast by Application (2026-2031)
